This Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), provides $821,426 to develop nanostructures that selectively target bacteria and create theoretical models to predict their behavior and interactions with bacteria. The project aims to address the growing problem of bacterial infections, particularly from Staphylococcus aureus and Acinetobacter baumannii, by designing nanostructures with intrinsic antibacterial activity and targeting capabilities using siderophore molecules. It also involves developing multi-resolution computational models to predict the shape, activity, and membrane disruption processes of the nanostructures. A sub-award of an unspecified amount was provided to Kansas State University to support specialized laboratory testing and diagnostic services related to the project.
Mod # | Description | Reason For Modification | Federal Obligation (Click to sort descending) | Date (Click to sort ascending) |
|---|---|---|---|---|
| Not listed | $0 | 4/29/25 | ||
| Not listed | $410.7k | 1/15/25 | ||
| Not listed | $410.7k | 1/15/25 |
Grant Number | Description | Subgrantee | Prime Award | Dollars Obligated (Click to sort descending) | Updated At (Click to sort ascending) |
|---|---|---|---|---|---|
3420052125001S | Kansas State University | Project Grant R01EB035543 | $110.2k | 3/5/25 |